SCHEMBL2092764

SCHEMBL2092764

Cc1cn([C@H]2CC[C@@H](OCP(=O)(O)O)O2)c(=O)[nH]c1=O

nearest known ligand 0.57

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TK1 P04183 8/20 0.55
POLB P06746 1/20 0.51
TYMP P19971 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL291317 1.00 TK1 (0.55) TK1POLBTYMP
SCHEMBL8711473 0.99 TK1 (0.54) TK1POLBTYMP
SCHEMBL8898158 0.99 TK1 (0.54) TK1POLBTYMP
SCHEMBL8896482 0.99 TK1 (0.54) TK1POLBTYMP
SCHEMBL8896487 0.89 TK1 (0.50) TK1POLB
SCHEMBL8897744 0.89 TK1 (0.53) TK1POLB
SCHEMBL8714093 0.87 TK1 (0.56) TK1POLB
SCHEMBL8895908 0.86 TK1 (0.47) TK1POLB
SCHEMBL12300469 0.83 TK1 (0.54) TK1POLBTYMP
SCHEMBL21473346 0.83 TK1 (0.57) TK1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119688420-A Method for detecting lead in high-salt food 山东省食品药品检验研究院 2025-03-25 CN claimed
CN-119505138-A Chiral covalent organic framework mimic enzyme catalyst and preparation method and application thereof 浙江工业大学 2025-02-25 CN claimed
CN-112564127-B Photovoltaic grid-connected power system frequency transient stability analysis method 武汉大学 2022-07-05 CN claimed
EP-4720348-A2 METHODS FOR MITIGATION OF METHYLATION BIAS Foundation Medicine, Inc. (US) 2026-04-08 EP disclosed
EP-4612293-A1 RUMINAL AND METHANOGEN VACCINES AND USES THEREOF Helix Nanotechnologies Inc (US) 2025-09-10 EP disclosed
CN-119979404-A Bacillus and application thereof in saline-alkali soil restoration and improvement and/or plant growth promotion 南京工业大学 2025-05-13 CN disclosed
CN-119948161-A Chimeric polypeptide systems and methods of gene regulation 安娜萨默尚帕利莫与卡洛斯蒙特斯尚帕利莫基金会-基金会研究中心 2025-05-06 CN disclosed
US-20250111889-A1 DE NOVO DESIGNED MACROCYCLIC OLIGOAMIDES UNIVERSITY OF WASHINGTON 2025-04-03 US disclosed
CN-119688420-A Method for detecting lead in high-salt food 山东省食品药品检验研究院 2025-03-25 CN disclosed
CN-119688420-A Method for detecting lead in high-salt food 山东省食品药品检验研究院 2025-03-25 CN disclosed
US-20250067454-A1 System and Method for Heating and Cooling Daikin Manufacturing Company, L.P. (US) 2025-02-27 US disclosed
CN-114843330-A Full-color Micro OLED and manufacturing method thereof 安徽熙泰智能科技有限公司 2022-08-02 CN disclosed
CN-114774571-A Traditional Chinese medicine intelligence-benefiting EST-SSR (expressed sequence tag-simple sequence repeat) labeled primer and application thereof 海南医学院 2022-07-22 CN disclosed
CN-114522245-A Targeted telomerase nano-drug delivery system and preparation method and application thereof 宿州学院 2022-05-24 CN disclosed
WO-2022072737-A1 SYSTEM, METHOD AND APPARATUS FOR PERSONAL VIROMETER Roswell Biotechnologies, Inc. (US) 2022-04-07 WO disclosed
US-8163718-B2 Nucleoside analogues containing phosphonate or phosphonamide groups GILEAD SCIENCES, INC. (US) 2012-04-24 US disclosed
US-20090232768-A1 NOVEL COMPOUNDS AND METHODS FOR THERAPY GILEAD SCIENCES, INC. (US) 2009-09-17 US disclosed
US-20050038058-A1 Novel compounds and methods for therapy INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY 2005-02-17 US disclosed
US-6225460-B1 PHOSPHOAMIDATE OR ESTER BOND THAT IS HYDROLYZED IN VIVO TO YIELD A CORRESPONDING PHOSPHONATE NUCLEOTIDE ANALOG. GILEAD SCIENCES, INC. 2001-05-01 US disclosed
US-5659023-A HETEROCYCLIC FURANOSYL OR PYRANOSYL PHOSPHONATE; IMMUNOGENS, OLIGONUCLEOTIDES, ANTIINFECTIVES, ANTIINFLAMMATORY AGENTS GILEAD SCIENCES, INC. (US) 1997-08-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038058-A1 Novel compounds and methods for therapy ZC3HAV1, IFNAR1, EIF2AK2 TK1 130/4885POLB 78/4885TYMP 30/4885
US-20250111889-A1 DE NOVO DESIGNED MACROCYCLIC OLIGOAMIDES DHFR, CCNH, ODC1 TK1 533/4885POLB 257/4885TYMP 310/4885
US-20090232768-A1 NOVEL COMPOUNDS AND METHODS FOR THERAPY TP53, ZC3HAV1, ZFX TK1 275/4885POLB 501/4885TYMP 269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.